Hyloris Pharmaceuticals SA (HYL.BR) - Quarterly Income Statement

Home
HYL.BR
Financials

4.52 (EUR) • At close November 12, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q2	2019 Q1
Revenue Numbers are in millions	1.527	1.527	0.58	0.58	0.677	0.677	1.033	0.516	2.258	1.129	0.838	0.419	0.047	0.047	0.019	0.063	0.008	0.008	0.035	0.04
Cost of Revenue Numbers are in millions	0.024	0.024	0.023	0.023	0.017	0.017	0.061	0.031	0.109	0.033	0.042	0.021	0.018	0.018	0.089	0.02	0.015	0.015	0.014	0.023
Gross Profit Numbers are in millions	1.504	1.504	0.557	0.557	0.661	0.661	0.972	0.486	2.149	1.097	0.796	0.398	0.029	0.029	-0.07	0.043	-0.007	-0.007	0.021	0.017
Gross Profit Ratio Numbers are in millions	0.985	0.985	0.96	0.96	0.976	0.976	0.941	0.941	0.952	0.971	0.95	0.95	0.613	0.613	-3.684	0.683	-0.813	-0.813	0.6	0.425
Reseach & Development Expenses Numbers are in millions	3.775	3.775	3.436	3.436	2.78	2.78	4.712	2.356	3.496	1.748	1.56	0.78	1.121	1.121	0.388	0.784	1.879	1.879	0.376	0.443
General & Administrative Expenses Numbers are in millions	0	0	0	0	0	0	0	0	1.449	1.449	0	0	0.131	0.131	1.931	0.523	0.246	0.246	0.18	0.136
Selling & Marketing Expenses Numbers are in millions	0	0	0	0	0	0	0	0	-0.201	-0.803	0	0	-0.001	-0.001	0	0	0.001	0.001	0	0
SG&A Numbers are in millions	1.528	1.528	1.245	1.245	1.122	1.122	1.274	0.637	1.248	0.646	1.608	0.804	0.13	0.13	1.931	0.523	0.246	0.246	0.18	0.136
Other Expenses Numbers are in millions	0.647	0	0	0	0	0	0	0	0	0	0	0	0	0	-0.02	0	0	0	-0.072	0
Operating Expenses Numbers are in millions	5.95	6.052	4.107	4.107	4.098	4.098	5.986	2.915	4.744	2.499	3.168	4.374	1.593	1.593	2.299	1.307	2.118	2.118	0.484	0.579
Operating Income Numbers are in millions	-4.447	-4.415	-3.508	-3.508	-3.345	-3.345	-5.014	-2.409	-2.595	-4.13	-2.372	-1.033	-0.722	-0.722	-2.369	-1.264	-0.523	-0.523	-0.463	-0.562
Operating Income Ratio Numbers are in millions	-2.912	-2.891	-6.048	-6.048	-4.941	-4.941	-4.854	-4.664	-1.149	-3.658	-2.831	-2.464	-15.516	-15.516	-124.684	-20.063	-65.375	-65.375	-13.229	-14.05
Total Other Income Expenses Net Numbers are in millions	0.074	0.042	0.191	0.191	-0.135	-0.135	-0.066	-0.062	-0.415	2.609	-6.096	-3.088	-0.98	-0.98	0.207	-0.315	-1.711	-1.711	-0.166	-0.123
Income Before Tax Numbers are in millions	-4.373	-4.373	-3.317	-3.317	-3.48	-3.48	-5.08	-2.471	-3.01	-1.521	-8.468	-4.12	-1.702	-1.702	-2.162	-1.579	-2.234	-2.234	-0.629	-0.685
Income Before Tax Ratio Numbers are in millions	-2.864	-2.864	-5.719	-5.719	-5.14	-5.14	-4.918	-4.784	-1.333	-1.347	-10.105	-9.833	-36.591	-36.591	-113.789	-25.063	-279.188	-279.188	-17.971	-17.125
Income Tax Expense Numbers are in millions	-0.302	0	-0.291	0	0.002	0.002	-0.196	0	0.216	0.149	-0.306	0	0	0	0.476	0.001	0.007	0.007	-0.049	0.006
Net Income Numbers are in millions	-4.373	-4.373	-3.317	-3.317	-3.482	-3.482	-4.942	-2.471	-3.339	-1.67	-8.24	-4.12	-1.702	-1.702	-2.638	-1.58	-2.148	-2.148	-0.58	-0.691
Net Income Ratio Numbers are in millions	-2.864	-2.864	-5.719	-5.719	-5.143	-5.143	-4.784	-4.784	-1.479	-1.479	-9.833	-9.833	-36.591	-36.591	-138.842	-25.079	-268.438	-268.438	-16.571	-17.275
EPS Numbers are in millions	-0.16	-0.16	-0.12	0	-0.12	-0.12	-0.19	-0.095	-0.13	-0.065	-0.32	-0.16	-0.067	-0.067	-0.1	-0.067	-0.2	-0.2	-0.025	-0.029
EPS Diluted Numbers are in millions	-0.16	-0.16	-0.12	0	-0.12	-0.12	-0.19	-0.094	-0.13	-0.065	-0.32	-0.16	-0.066	-0.066	-0.1	-0.067	-0.2	-0.2	-0.025	-0.029
EBITDA Numbers are in millions	-4.389	-4.37	-3.427	-3.427	-3.335	-3.335	-4.959	-2.382	-2.507	-4.117	-2.346	-1.02	-0.71	-0.71	-1.658	-1.324	-0.51	-0.51	-0.526	-0.544
EBITDA Ratio Numbers are in millions	-2.874	-2.862	-5.908	-5.908	-4.926	-4.926	-4.801	-4.611	-1.11	-3.647	-2.8	-2.433	-15.258	-15.258	-87.263	-21.016	-63.812	-63.812	-15.029	-13.6

Hyloris Pharmaceuticals SA

EBR:HYL.BR Add to watchlist

EBR:HYL.BR